Search

MSK’s SPORE grant in leukemia has the potential to develop practice-changing approaches, evaluation, and management that may lead to improved patient outcomes for AML.

… Tuesday, September 7, 2021 The National Cancer Institute (NCI) recently awarded Memorial Sloan Kettering Cancer Center (MSK) with a prestigious Specialized Programs of Research Excellence (SPORE) grant for leukemia research. The Translational Research Program (TRP) is the home of the SPOREs — a cornerstone

Memorial Sloan Kettering’s 42nd annual ceremony recognized graduates and award winners with a virtual ceremony.

… Thursday, May 20, 2021 Memorial Sloan Kettering’s 42nd annual Academic Convocation and Commencement ceremony, which took place on May 19, 2021, was held virtually for a second year due to the COVID-19 pandemic. Four members of MSK’s leadership team took to the stage in the Zuckerman Research Center,

At Memorial Sloan Kettering Cancer Center, we have now analyzed more than 50,000 samples in our prospective cohort with MSK-IMPACT™.

… Wednesday, February 24, 2021 At Memorial Sloan Kettering Cancer Center, we have now analyzed over 65,000 samples in our prospective cohort with MSK-IMPACT™ , our next-generation sequencing (NGS) platform, and are adding to that number every day. This is up 8000 from January this year, despite Covid-19

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Luis Alberto Diaz, Jr., MD, Head of the Division of Solid Tumor Oncology; Grayer Family Chair at MSK, has been elected to the 10th class of Giants of Cancer Care® for his contributions in translational science.

… Monday, May 9, 2022 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Luis Alberto Diaz, Jr., MD, Head of the Division of Solid Tumor Oncology; Grayer Family Chair at MSK, has been elected to the 10 th class of Giants of Cancer Care® for his contributions in translational science. The

Learn how immune cells in the lungs trigger invasive fungal cells to self-destruct. The discovery could produce therapies to prevent infection in cancer patients.

… Thursday, September 7, 2017 Summary Due to their weakened immune function, cancer patients who receive bone marrow transplants are at a high risk of infection from a common fungus called Aspergillus fumigatus . Researchers discovered that immune cells in the lungs of healthy people kill the fungal cells

Learn how Memorial Sloan Kettering Cancer Center kept caring for patients during the response to COVID-19, and how lessons learned during the pandemic are helping cancer care.

… Thursday, October 1, 2020 “It felt like watching a terrifying storm moving toward us in slow motion.” That is how Memorial Sloan Kettering lymphoma doctor Matthew Matasar describes watching the COVID-19 pandemic unfold. MSK doctors, researchers, and staff never wavered in their commitment to continue

The Hartford HealthCare Cancer Institute has been formally certified as the charter member of the Memorial Sloan Kettering Cancer Alliance, a transformative initiative to improve the quality of care and outcomes for cancer patients in community healthcare settings.

… Tuesday, September 16, 2014 The Hartford HealthCare Cancer Institute (HHCCI) has been formally certified as the charter member of the Memorial Sloan Kettering (MSK) Cancer Alliance, a transformative initiative to improve the quality of care and outcomes for cancer patients in community healthcare settings

… Wednesday, September 28, 2022 When you ask Jose Casa what he does for a living he says, “I get paid to talk trash.” His answer — delivered with a comedian’s expert timing — clearly oversimplifies the important role Jose has played at Memorial Sloan Kettering Cancer Center (MSK) for almost three decades

In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed and treated at MSK.

… Tuesday, July 26, 2022 Many tumors can be eliminated with surgery , chemotherapy , radiation , and other treatments. But once cancer spreads, or metastasizes, to other parts of the body, it becomes much harder to stop. In this Q&A, medical oncologist Emily Feld talks about how metastatic cancer is diagnosed

Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of.

… Tuesday, October 1, 2013 Summary Memorial Sloan Kettering researchers have discovered how a common bacterium can evolve to become more mobile and easier to get rid of. VIDEO | 00:14 The Social Behavior of Bacteria Offers New Ideas for Antimicrobial Drug Design Video Details This movie clip shows Pseudomonas